
1.88 Delayed Data As of Jan 27 | ![]() Today’s Change | 1.60 Today|||52-Week Range 5.04 | -1.05% Year-to-Date |
The 8 analysts offering 12-month price forecasts for Autolus Therapeutics PLC have a median target of 7.00, with a high estimate of 18.00 and a low estimate of 2.20. The median estimate represents a +272.34% increase from the last price of 1.88.
The current consensus among 9 polled investment analysts is to Buy stock in Autolus Therapeutics PLC. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.